SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-248533
Filing Date
2018-08-14
Accepted
2018-08-14 16:33:55
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d579397d10q.htm 10-Q 858357
2 EX-10.5 d579397dex105.htm EX-10.5 34704
3 EX-31.1 d579397dex311.htm EX-31.1 7023
4 EX-31.2 d579397dex312.htm EX-31.2 6801
5 EX-32.1 d579397dex321.htm EX-32.1 3536
6 EX-32.2 d579397dex322.htm EX-32.2 3508
13 GRAPHIC g579397snap0001.jpg GRAPHIC 10006
14 GRAPHIC g579397snap0002.jpg GRAPHIC 3580
  Complete submission text file 0001193125-18-248533.txt   3548723

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cnst-20180630.xml EX-101.INS 573263
8 XBRL TAXONOMY EXTENSION SCHEMA cnst-20180630.xsd EX-101.SCH 39939
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20180630_cal.xml EX-101.CAL 50954
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20180630_def.xml EX-101.DEF 122091
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20180630_lab.xml EX-101.LAB 291389
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20180630_pre.xml EX-101.PRE 217327
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 181018173
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1